Article

Letter to the Editor

Ann Lab Med 2024; 44(3): 303-305

Published online May 1, 2024 https://doi.org/10.3343/alm.2023.0361

Copyright © Korean Society for Laboratory Medicine.

The First Case of Congenital Nephrogenic Diabetes Insipidus Caused by AVPR2 Disruption Because of 4q25 Insertional Translocation

Boram Kim, M.D.1* , Yo Han Ahn, M.D., Ph.D.2* , Jae Hyeon Park, M.D.3 , Han Sol Lim, M.S.3 , Seung Won Chae, M.S.3,4 , Jee-Soo Lee, M.D., Ph.D.3 , Hee Gyung Kang, M.D., Ph.D.2 , Man Jin Kim, M.D., Ph.D.5 , and Moon-Woo Seong, M.D., Ph.D.3,4

1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 2Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea; 3Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; 4Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 5Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea

Correspondence to: Moon-Woo Seong, M.D., Ph.D.
Department of Laboratory Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
E-mail: mwseong@snu.ac.kr

Man Jin Kim, M.D., Ph.D.
Department of Genomic Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
E-mail: number1@snu.ac.kr

*These authors equally contributed to this study.

Received: September 11, 2023; Revised: October 11, 2023; Accepted: December 8, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Dear Editor,

Congenital nephrogenic diabetes insipidus (NDI) is characterized by an impaired renal response to arginine vasopressin (AVP) [1]. Approximately 90% of patients with NDI have mutations in the AVP receptor 2 gene (AVPR2) [2]. Mutations in AVPR2 located in chromosome X result in X-linked NDI, which presents characteristic symptoms, including polyuria, polydipsia, and fever in male infants.

A two-month-old boy (Pt #1) presented to Seoul National University Hospital with irritability, polyuria, and mild fever in March 2023. Informed consent was obtained from the patient’s guardian. During a water deprivation test, he exhibited an elevated serum sodium level and a continuous decrease in urine osmolality, which were not alleviated by subcutaneous vasopressin injection. The family history indicated X-linked recessive inheritance (Fig. 1A). The patient’s second uncle (Pt #2) with similar symptom as his nephew had also been diagnosed as having NDI as an infant.

Figure 1. AVPR2 next-generation sequencing and breakpoint analysis results. (A) Pedigree showing a typical X-linked recessive inheritance pattern. (B) Next-generation sequencing results revealed a soft clipped region in intron 2 of AVPR2. (C) Based on the results of analysis of the chimeric reads, PCR was performed targeting the suspected breakpoint. A fragment with the expected amplicon size of 400 bp was identified in gel electrophoresis. Sanger sequencing confirmed that the upstream from chrX:153,170,697 and the downstream from chr4:109,062,641 were joined. Specifically, exons 1–2 of AVPR2 and exons 1–3 of LEF1 were joined in opposite transcriptional orientations. (D) In chromosomal microarray analysis, a 497-kb heterozygous duplication in the 4q25 region was observed and described as “arr[GRCh37] 4q25(109062645_109559599)×3” according to the International System for Human Cytogenetic Nomenclature. (E) Based on the combined results, we concluded that a 497-kb insertional translocation occurred in the center of AVPR2.

We performed whole-exome sequencing of a blood sample of Pt #2. A soft-clipped region was observed in intron 2 of AVPR2, using Integrative Genomics Viewer (Fig. 1B). Analysis of chimeric reads revealed a putative chromosomal translocation between the long arms of chromosome 4 and chromosome X. Primers for the suspected breakpoints were designed, and PCR was performed. Subsequent Sanger sequencing revealed breakpoints at chrX:153,170,697 and chr4:109,062,641 (Fig. 1C). Karyotyping was performed to confirm the translocation. Surprisingly, chromosomal analysis revealed normal findings (data not shown). Subsequently, a chromosomal microarray assay was performed on peripheral blood from Pt #1, using the CytoScan Dx Assay (Affymetrix, Santa Clara, CA, USA) per the manufacturer’s instructions. The fusion in Pt #1 was validated using breakpoint PCR (data not shown). Chromosomal analysis revealed a 497-kb duplication, encompassing exons 1–3 of the lymphoid enhancer-binding factor 1 gene (LEF1) (Fig. 1D). AVPR2 copy number variation was not observed (data not shown). Considering the combined results, we hypothesized that a fusion between AVPR2 and LEF1 had occurred through the insertional translocation of the 497-kb segment within the 4q25 region, involving exons 1–3 of LEF1 (Fig. 1E). The insertional translocation of the 497-kb segment generates a fusion with AVPR2 and LEF1 exons in opposite transcriptional orientations. Consequently, this fusion is expected to cause loss of function of AVPR2 as it cannot produce a normal transcript.

Studies have suggested an association between monoallelic/biallelic loss-of-function variants in LEF1 and ectodermal dysplasia [3, 4]. Our patient did not show any symptoms associated with ectodermal dysplasia. This discrepancy may be attributed to the presence of two normal LEF1 alleles, regardless of the insertional translocation. As the resolution of karyotyping typically is around 5 Mb, the 497-kb insertional translocation was not detected by this method. Given the challenges in detecting insertional translocationusing next-generation sequencing, gap-PCR is recommended for undiagnosed cases of NDI with suspected X-linked recessive inheritance.

In conclusion, we identified a novel disruption of AVPR2 due to 4q25 insertional translocationin a family with NDI. To the best of our knowledge, this is the first documented case of NDI resulting from insertional translocation.

Kim B and Kim MJ conceived the idea. Kim MJ and Ahn YH drafted the manuscript and designed the figure. Park JH wrote the methods part and provided the raw figure. Lim HS and Chae SW performed the experiments. Kim MJ and Seong M supervised the study. All authors reviewed the manuscript and approved the final manuscript.

This study was supported by a grant (6500-6534-306) from the Korea Disease Control and Prevention Agency.

  1. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11:576-88.
    Pubmed CrossRef
  2. Knoers N and Lemmink H. Hereditary Nephrogenic Diabetes Insipidus. In: Adam MP, Everman DB, et al., eds. GeneReviews. Seattle: University of Washington, 1993.
  3. Dufour W, Alawbathani S, Jourdain AS, Asif M, Baujat G, Becker C, et al. Monoallelic and biallelic variants in LEF1 are associated with a new syndrome combining ectodermal dysplasia and limb malformations caused by altered WNT signaling. Genet Med 2022;24:1708-21.
    Pubmed CrossRef
  4. Lévy J, Capri Y, Rachid M, Dupont C, Vermeesch JR, Devriendt K, et al. LEF1 haploinsufficiency causes ectodermal dysplasia. Clin Genet 2020;97:595-600.
    Pubmed CrossRef